超详细!这4大类祛痰药到底怎么用,一篇文章总结全了!

2022-01-04 图图 MedSci原创

虽然镇咳药常与祛痰剂、平喘药、抗过敏药或镇痛剂合用,但也要避免过多使用祛痰药物,同时应用多种祛痰剂因强烈刺激气道腺体分泌黏液反而使咳嗽加剧。

黏液的分泌和清除对于气道完整性和肺部防御极为重要。正常情况下,黏液在气流和纤毛的作用下从下呼吸道转移到咽部。但当黏液的分泌量或成分改变、纤毛清除功能下降、咳嗽能力不足时,可造成黏液无法有效排出,潴留于气道,与鼻咽、口咽分泌物、细胞碎片和微生物共同形成痰液。

 

临床常用祛痰方法

 

包括危险因素干预、物理祛痰以及药物祛痰:

 

1、危险因素干预:如积极戒烟、减少颗粒物暴露、防治呼吸道感染吸烟是气道黏液高分泌最常见的危险因素,因此戒烟对于祛痰管理尤为重要。

 

2、物理祛痰:包括指导患者深呼吸和有效咳嗽、胸背部叩击、体位排痰以及呼气末正压(PEEP)和胸壁高频振荡(HFCWO)等。湿化疗法也是物理祛痰方式的一种,通过湿化气道可降低分泌物黏稠度以促进排出。有报道通过吸入空气中饱和的岩盐气溶胶微粒(直径1~5 μm,浓度3 mg/m3以上),可改善支气管内容物的流变性,从而促进黏液廓清。

 

3、药物祛痰:给药途径有雾化吸入、口服及静脉滴注。药物雾化吸入除在局部发挥祛痰作用外,同时可湿化气道。

 

四大类祛痰药物

 

根据《雾化祛痰临床应用的中国专家共识》(2021年),目前临床常用祛痰药物按照作用机制可分为4类:

 

恶心性祛痰剂:促进痰液从呼吸道排出的药物,如高渗生理盐水雾化吸入,愈创甘油醚;

 

黏液溶解剂:即通过裂解黏蛋白复合物间二硫键等方式促进痰液溶解和排出,如N-乙酰半胱氨酸(NAC)和厄多司坦;

 

黏液调节剂:即通过促进浆液分泌、减少黏蛋白生成等方式调节黏液分泌,主要有氨溴索、溴己新、羧甲司坦等,糖皮质激素和抗胆碱能药物也具有抑制黏液分泌作用;

 

黏液动力药:即通过促进气道黏膜纤毛运动、改善黏液清除动力学帮助排痰,包括桃金娘油、桉柠蒎、β肾上腺能受体激动剂。此外,一些复方中成药也具有祛痰作用。

 

常用祛痰药物的特点及用法如下:

 

 

宫巧俐,沈司京.祛痰药物的合理应用[J].中国医刊,2008,(07):59-62.

 

使用祛痰药物的注意事项:

  • 虽然镇咳药常与祛痰剂、平喘药、抗过敏药或镇痛剂合用,但也要避免过多使用祛痰药物,同时应用多种祛痰剂因强烈刺激气道腺体分泌黏液反而使咳嗽加剧。

  • 恶心性祛痰药剂量不宜过大以免引起呕吐。因能促使胃酸分泌增加所以对溃疡病患者应慎用。

  • 服用氯化铵时应多饮水。

  • 当痰量较多时不宜使用镇咳药,尤其是喷托维林、苯丙哌林等‚此类镇咳药会阻断咳嗽反射导致痰液滞留于气道既影响呼吸又易继发感染故宜先祛痰为主止咳为辅,痰液排出咳嗽自然停止。

  • 中草药制剂应根据其药物的辨证合理选择切不可盲目滥用。

 

参考文献:

1.梁盛华,许志威.镇咳、祛痰药物研究进展[J].中国药房,2015,26(25):3578-3580.

2.宫巧俐,沈司京.祛痰药物的合理应用[J].中国医刊,2008,(07):59-62.

3.任常陵.祛痰药物的分类及其使用方法[J].日本医学介绍,2007(10):468-469.

4.石力夫.祛痰药物知识问答(Ⅰ)[J].药学服务与研究,2011,11(02):161-162.

5.石力夫.祛痰药物知识问答(Ⅱ)[J].药学服务与研究,2011,11(03):241-242.

6. 雾化祛痰临床应用的中国专家共识[J].中华结核和呼吸杂志,2021,44(04):340-348.

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (15)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1184102, encodeId=726611841025b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67a56419588, createdName=ms4000000813024725, createdTime=Fri Jan 14 05:55:31 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182476, encodeId=a3da11824e6f6, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79f56455521, createdName=ms5000000520551871, createdTime=Sun Jan 09 11:26:44 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182325, encodeId=9a971182325d0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d325478412, createdName=ms1000001741405932, createdTime=Sat Jan 08 19:16:42 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182224, encodeId=1cbc118222436, content=学习了,有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cadc6445741, createdName=ms8000001999886379, createdTime=Sat Jan 08 15:25:14 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182048, encodeId=b996118204805, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=073e6454334, createdName=ms3000001536532008, createdTime=Sat Jan 08 01:41:07 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181616, encodeId=f2b71181616d1, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Thu Jan 06 23:19:11 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180748, encodeId=74c51180e48c1, content=防治及用药的高度重视,HIV双药单一片剂, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Wed Jan 05 07:31:52 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180601, encodeId=67aa11806015a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3665228215, createdName=147953cem6, createdTime=Tue Jan 04 22:08:19 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180576, encodeId=3ea411805e676, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Tue Jan 04 21:11:50 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180563, encodeId=d6f8118056368, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=659a3947245, createdName=13913396m26暂无昵称, createdTime=Tue Jan 04 20:41:12 CST 2022, time=2022-01-04, status=1, ipAttribution=)]
    2022-01-14 ms4000000813024725

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1184102, encodeId=726611841025b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67a56419588, createdName=ms4000000813024725, createdTime=Fri Jan 14 05:55:31 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182476, encodeId=a3da11824e6f6, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79f56455521, createdName=ms5000000520551871, createdTime=Sun Jan 09 11:26:44 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182325, encodeId=9a971182325d0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d325478412, createdName=ms1000001741405932, createdTime=Sat Jan 08 19:16:42 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182224, encodeId=1cbc118222436, content=学习了,有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cadc6445741, createdName=ms8000001999886379, createdTime=Sat Jan 08 15:25:14 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182048, encodeId=b996118204805, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=073e6454334, createdName=ms3000001536532008, createdTime=Sat Jan 08 01:41:07 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181616, encodeId=f2b71181616d1, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Thu Jan 06 23:19:11 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180748, encodeId=74c51180e48c1, content=防治及用药的高度重视,HIV双药单一片剂, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Wed Jan 05 07:31:52 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180601, encodeId=67aa11806015a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3665228215, createdName=147953cem6, createdTime=Tue Jan 04 22:08:19 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180576, encodeId=3ea411805e676, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Tue Jan 04 21:11:50 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180563, encodeId=d6f8118056368, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=659a3947245, createdName=13913396m26暂无昵称, createdTime=Tue Jan 04 20:41:12 CST 2022, time=2022-01-04, status=1, ipAttribution=)]
    2022-01-09 ms5000000520551871

    很有用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1184102, encodeId=726611841025b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67a56419588, createdName=ms4000000813024725, createdTime=Fri Jan 14 05:55:31 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182476, encodeId=a3da11824e6f6, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79f56455521, createdName=ms5000000520551871, createdTime=Sun Jan 09 11:26:44 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182325, encodeId=9a971182325d0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d325478412, createdName=ms1000001741405932, createdTime=Sat Jan 08 19:16:42 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182224, encodeId=1cbc118222436, content=学习了,有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cadc6445741, createdName=ms8000001999886379, createdTime=Sat Jan 08 15:25:14 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182048, encodeId=b996118204805, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=073e6454334, createdName=ms3000001536532008, createdTime=Sat Jan 08 01:41:07 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181616, encodeId=f2b71181616d1, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Thu Jan 06 23:19:11 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180748, encodeId=74c51180e48c1, content=防治及用药的高度重视,HIV双药单一片剂, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Wed Jan 05 07:31:52 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180601, encodeId=67aa11806015a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3665228215, createdName=147953cem6, createdTime=Tue Jan 04 22:08:19 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180576, encodeId=3ea411805e676, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Tue Jan 04 21:11:50 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180563, encodeId=d6f8118056368, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=659a3947245, createdName=13913396m26暂无昵称, createdTime=Tue Jan 04 20:41:12 CST 2022, time=2022-01-04, status=1, ipAttribution=)]
    2022-01-08 ms1000001741405932

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1184102, encodeId=726611841025b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67a56419588, createdName=ms4000000813024725, createdTime=Fri Jan 14 05:55:31 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182476, encodeId=a3da11824e6f6, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79f56455521, createdName=ms5000000520551871, createdTime=Sun Jan 09 11:26:44 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182325, encodeId=9a971182325d0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d325478412, createdName=ms1000001741405932, createdTime=Sat Jan 08 19:16:42 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182224, encodeId=1cbc118222436, content=学习了,有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cadc6445741, createdName=ms8000001999886379, createdTime=Sat Jan 08 15:25:14 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182048, encodeId=b996118204805, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=073e6454334, createdName=ms3000001536532008, createdTime=Sat Jan 08 01:41:07 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181616, encodeId=f2b71181616d1, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Thu Jan 06 23:19:11 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180748, encodeId=74c51180e48c1, content=防治及用药的高度重视,HIV双药单一片剂, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Wed Jan 05 07:31:52 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180601, encodeId=67aa11806015a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3665228215, createdName=147953cem6, createdTime=Tue Jan 04 22:08:19 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180576, encodeId=3ea411805e676, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Tue Jan 04 21:11:50 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180563, encodeId=d6f8118056368, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=659a3947245, createdName=13913396m26暂无昵称, createdTime=Tue Jan 04 20:41:12 CST 2022, time=2022-01-04, status=1, ipAttribution=)]
    2022-01-08 ms8000001999886379

    学习了,有用

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1184102, encodeId=726611841025b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67a56419588, createdName=ms4000000813024725, createdTime=Fri Jan 14 05:55:31 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182476, encodeId=a3da11824e6f6, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79f56455521, createdName=ms5000000520551871, createdTime=Sun Jan 09 11:26:44 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182325, encodeId=9a971182325d0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d325478412, createdName=ms1000001741405932, createdTime=Sat Jan 08 19:16:42 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182224, encodeId=1cbc118222436, content=学习了,有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cadc6445741, createdName=ms8000001999886379, createdTime=Sat Jan 08 15:25:14 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182048, encodeId=b996118204805, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=073e6454334, createdName=ms3000001536532008, createdTime=Sat Jan 08 01:41:07 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181616, encodeId=f2b71181616d1, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Thu Jan 06 23:19:11 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180748, encodeId=74c51180e48c1, content=防治及用药的高度重视,HIV双药单一片剂, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Wed Jan 05 07:31:52 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180601, encodeId=67aa11806015a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3665228215, createdName=147953cem6, createdTime=Tue Jan 04 22:08:19 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180576, encodeId=3ea411805e676, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Tue Jan 04 21:11:50 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180563, encodeId=d6f8118056368, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=659a3947245, createdName=13913396m26暂无昵称, createdTime=Tue Jan 04 20:41:12 CST 2022, time=2022-01-04, status=1, ipAttribution=)]
    2022-01-08 ms3000001536532008

    学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1184102, encodeId=726611841025b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67a56419588, createdName=ms4000000813024725, createdTime=Fri Jan 14 05:55:31 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182476, encodeId=a3da11824e6f6, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79f56455521, createdName=ms5000000520551871, createdTime=Sun Jan 09 11:26:44 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182325, encodeId=9a971182325d0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d325478412, createdName=ms1000001741405932, createdTime=Sat Jan 08 19:16:42 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182224, encodeId=1cbc118222436, content=学习了,有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cadc6445741, createdName=ms8000001999886379, createdTime=Sat Jan 08 15:25:14 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182048, encodeId=b996118204805, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=073e6454334, createdName=ms3000001536532008, createdTime=Sat Jan 08 01:41:07 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181616, encodeId=f2b71181616d1, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Thu Jan 06 23:19:11 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180748, encodeId=74c51180e48c1, content=防治及用药的高度重视,HIV双药单一片剂, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Wed Jan 05 07:31:52 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180601, encodeId=67aa11806015a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3665228215, createdName=147953cem6, createdTime=Tue Jan 04 22:08:19 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180576, encodeId=3ea411805e676, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Tue Jan 04 21:11:50 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180563, encodeId=d6f8118056368, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=659a3947245, createdName=13913396m26暂无昵称, createdTime=Tue Jan 04 20:41:12 CST 2022, time=2022-01-04, status=1, ipAttribution=)]
    2022-01-06 ms7000000167247375

    学习#学习#

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1184102, encodeId=726611841025b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67a56419588, createdName=ms4000000813024725, createdTime=Fri Jan 14 05:55:31 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182476, encodeId=a3da11824e6f6, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79f56455521, createdName=ms5000000520551871, createdTime=Sun Jan 09 11:26:44 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182325, encodeId=9a971182325d0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d325478412, createdName=ms1000001741405932, createdTime=Sat Jan 08 19:16:42 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182224, encodeId=1cbc118222436, content=学习了,有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cadc6445741, createdName=ms8000001999886379, createdTime=Sat Jan 08 15:25:14 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182048, encodeId=b996118204805, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=073e6454334, createdName=ms3000001536532008, createdTime=Sat Jan 08 01:41:07 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181616, encodeId=f2b71181616d1, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Thu Jan 06 23:19:11 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180748, encodeId=74c51180e48c1, content=防治及用药的高度重视,HIV双药单一片剂, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Wed Jan 05 07:31:52 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180601, encodeId=67aa11806015a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3665228215, createdName=147953cem6, createdTime=Tue Jan 04 22:08:19 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180576, encodeId=3ea411805e676, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Tue Jan 04 21:11:50 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180563, encodeId=d6f8118056368, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=659a3947245, createdName=13913396m26暂无昵称, createdTime=Tue Jan 04 20:41:12 CST 2022, time=2022-01-04, status=1, ipAttribution=)]
    2022-01-05 查查佳佳

    防治及用药的高度重视,HIV双药单一片剂

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1184102, encodeId=726611841025b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67a56419588, createdName=ms4000000813024725, createdTime=Fri Jan 14 05:55:31 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182476, encodeId=a3da11824e6f6, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79f56455521, createdName=ms5000000520551871, createdTime=Sun Jan 09 11:26:44 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182325, encodeId=9a971182325d0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d325478412, createdName=ms1000001741405932, createdTime=Sat Jan 08 19:16:42 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182224, encodeId=1cbc118222436, content=学习了,有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cadc6445741, createdName=ms8000001999886379, createdTime=Sat Jan 08 15:25:14 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182048, encodeId=b996118204805, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=073e6454334, createdName=ms3000001536532008, createdTime=Sat Jan 08 01:41:07 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181616, encodeId=f2b71181616d1, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Thu Jan 06 23:19:11 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180748, encodeId=74c51180e48c1, content=防治及用药的高度重视,HIV双药单一片剂, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Wed Jan 05 07:31:52 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180601, encodeId=67aa11806015a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3665228215, createdName=147953cem6, createdTime=Tue Jan 04 22:08:19 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180576, encodeId=3ea411805e676, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Tue Jan 04 21:11:50 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180563, encodeId=d6f8118056368, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=659a3947245, createdName=13913396m26暂无昵称, createdTime=Tue Jan 04 20:41:12 CST 2022, time=2022-01-04, status=1, ipAttribution=)]
    2022-01-04 147953cem6

    学习了

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1184102, encodeId=726611841025b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67a56419588, createdName=ms4000000813024725, createdTime=Fri Jan 14 05:55:31 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182476, encodeId=a3da11824e6f6, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79f56455521, createdName=ms5000000520551871, createdTime=Sun Jan 09 11:26:44 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182325, encodeId=9a971182325d0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d325478412, createdName=ms1000001741405932, createdTime=Sat Jan 08 19:16:42 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182224, encodeId=1cbc118222436, content=学习了,有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cadc6445741, createdName=ms8000001999886379, createdTime=Sat Jan 08 15:25:14 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182048, encodeId=b996118204805, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=073e6454334, createdName=ms3000001536532008, createdTime=Sat Jan 08 01:41:07 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181616, encodeId=f2b71181616d1, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Thu Jan 06 23:19:11 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180748, encodeId=74c51180e48c1, content=防治及用药的高度重视,HIV双药单一片剂, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Wed Jan 05 07:31:52 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180601, encodeId=67aa11806015a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3665228215, createdName=147953cem6, createdTime=Tue Jan 04 22:08:19 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180576, encodeId=3ea411805e676, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Tue Jan 04 21:11:50 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180563, encodeId=d6f8118056368, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=659a3947245, createdName=13913396m26暂无昵称, createdTime=Tue Jan 04 20:41:12 CST 2022, time=2022-01-04, status=1, ipAttribution=)]
    2022-01-04 屋顶瞄爱赏月

    学习

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1184102, encodeId=726611841025b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67a56419588, createdName=ms4000000813024725, createdTime=Fri Jan 14 05:55:31 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182476, encodeId=a3da11824e6f6, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79f56455521, createdName=ms5000000520551871, createdTime=Sun Jan 09 11:26:44 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182325, encodeId=9a971182325d0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d325478412, createdName=ms1000001741405932, createdTime=Sat Jan 08 19:16:42 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182224, encodeId=1cbc118222436, content=学习了,有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cadc6445741, createdName=ms8000001999886379, createdTime=Sat Jan 08 15:25:14 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182048, encodeId=b996118204805, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=073e6454334, createdName=ms3000001536532008, createdTime=Sat Jan 08 01:41:07 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181616, encodeId=f2b71181616d1, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Thu Jan 06 23:19:11 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180748, encodeId=74c51180e48c1, content=防治及用药的高度重视,HIV双药单一片剂, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Wed Jan 05 07:31:52 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180601, encodeId=67aa11806015a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3665228215, createdName=147953cem6, createdTime=Tue Jan 04 22:08:19 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180576, encodeId=3ea411805e676, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Tue Jan 04 21:11:50 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180563, encodeId=d6f8118056368, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=659a3947245, createdName=13913396m26暂无昵称, createdTime=Tue Jan 04 20:41:12 CST 2022, time=2022-01-04, status=1, ipAttribution=)]
    2022-01-04 13913396m26暂无昵称

    学习了

    0

相关资讯

9种祛痰药,你选择对了吗?

祛痰药在呼吸科是非常常用的药物,作为呼吸科医生常用祛痰药的适应症和注意事项你都知道吗?临床中你的选择对吗?

祛痰药用得不少,但你未必真的会用

临床医生在应用祛痰药物时不仅应当了解各种呼吸疾病发生排痰障碍和咳痰增多的机制,还应当熟悉各种祛痰药物的作用机制和特点,有的放矢地选用各种祛痰药物,使之各尽所长,达到最佳疗效。